Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02919332 : Delayed 18F-FDG PET/CT in Improving Visualization of Brain Tumors in Patients With Glioblastoma
PhaseN/A
AgesMin: 18 Years Max: 99 Years
Eligibility
Inclusion Criteria:

- Patients with histologically proven high grade glioma scheduled for 18F-FDG PET/CT

Exclusion Criteria:

- Severe psychiatric illness

- Inability to give written consent

- Breast feeding/pregnancy
LinksPermanent Link to THIS page: http://virtualtrials.com/nct/display1trial.cfm?nct=NCT02919332      |      Link to official Clinicaltrials.gov listing
Locations
Los Angeles, California
Facility: UCLA / Jonsson Comprehensive Cancer Center
Investigator: Johannes Czernin
Contact: Johannes Czernin Phone: 310-794-1005
Email not avaialable




Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2017 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites